secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forian Inc. (FORA)
CIK:        0001829280
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001140361-23-024388
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forian Q1 revenue up 38% to $4.9M; continuing ops loss narrows to $2.2M
-----------------------------------------------------------------------

- Revenue $4.87M, +38% YoY; continuing ops net loss $2.25M vs $10.3M loss in prior year.
- Adjusted EBITDA from continuing ops improved to -$0.27M from -$2.7M YoY.
- Discontinued ops contributed $8.7M net income from February 2023 sale of BioTrack cannabis business.
- Cash, cash equivalents and marketable securities totaled $40M at March 31, 2023.
- Company transitions to pure-play healthcare information provider after divesting cannabis software.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829280/000114036123024388/0001140361-23-024388-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829280/000114036123024388/brhc20052853_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-024388

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer